Article Details

Sangamo's Novel Gene Therapy for Chronic Pain Gets FDA Clearance for Clinical Trials

Retrieved on: 2024-11-19 21:25:06

Tags for this article:

Click the tags to see associated articles and topics

Sangamo's Novel Gene Therapy for Chronic Pain Gets FDA Clearance for Clinical Trials. View article details on hiswai:

Excerpt

... gene therapy targeting chronic neuropathic pain. Phase 1/2 trials set to begin mid-2025 for small fiber neuropathy treatment.

Article found on: www.stocktitan.net

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up